Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Ma, Bookman"'
Autor:
Js, Huston, Andrew George, Gp, Adams, Wf, Stafford, Jamar F, Ms, Tai, Je, Mccartney, Oppermann H, Bt, Heelan, Am, Peters, Ll, Houston, Ma, Bookman, Ej, Wolf, Lm, Weiner
Publikováno v:
Europe PubMed Central
The availability of engineered antibody species has catalyzed new developments in radioimmunotargeting. This chapter summarized recent studies of single-chain Fv (sFv) proteins, which are minimal antibody binding sites engineered as single polypeptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::be0a7986eb548391a296820429d4f1ce
http://europepmc.org/abstract/med/8961808
http://europepmc.org/abstract/med/8961808
Autor:
Sehouli J; Gynecology with Center for Oncological Surgery, Charite Universitatsmedizin Berlin, Berlin, Germany jalid.sehouli@charite.de.; North-Eastern German Society of Gynaecological Oncology (NOGGO eV), Berlin, Germany., Boer J; North-Eastern German Society of Gynaecological Oncology (NOGGO eV), Berlin, Germany., Brand AH; Westmead Hospital, Westmead, New South Wales, Australia.; The Gynecologic Cancer InterGroup, Kingston, Ontario, Canada., Oza AM; Medical Oncology & Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., O'Donnell J; The Gynecologic Cancer InterGroup, Kingston, Ontario, Canada., Bennett K; The Gynecologic Cancer InterGroup, Kingston, Ontario, Canada., Glaspool R; Beatson West of Scotland Cancer Centre, Glasgow, UK., Lee CK; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia., Ethier JL; Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Harter P; Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.; AGO Study Group, Wiesbaden, Germany., Seebacher-Shariat V; AGO Austria, Innsbruck, Austria.; Medical University of Vienna, Vienna, Austria., Chang TC; Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Chang Gung University, Taoyuan, Taiwan., Cohen PA; Australia New Zealand Gynaecological Oncology Group (ANZGOG), Camperdown, New South Wales, Australia., van Gorp T; Gynaecological Oncology, KU Leuven University Hospitals Leuven, Leuven, Belgium., Chavez-Blanco A; The Gynecologic Cancer InterGroup, Kingston, Ontario, Canada., Welch S; Department of Oncology, Western University Schulich School of Medicine & Dentistry, London, Ontario, Canada., Hranovska H; National Academy of Medical Sciences of Ukraine, Kiiv, Ukraine., O'Toole S; Cancer Trials Ireland, Dublin, Ireland., Lok CAR; Department of Gynaecologic Oncology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands., Madariaga A; 12 de Octubre University Hospital, Madrid, Comunidad de Madrid, Spain.; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Rauh-Hain JA; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Perez Fidalgo A; Medical Oncology, Hospital Clinico Universitario, Valencia, Spain., Tan D; National University Cancer Institute, Singapore., Michels J; Gustave Roussy, Villejuif, Île-de-France, France.; Université Paris-Saclay, Villejuif, Île-de-France, France., Pothuri B; NYU Langone Health Perlmutter Cancer Center, New York, New York, USA., Fujiwara N; Department of Palliative Medicine and Advanced Clinical Oncology, IMSUT Hospital of the Institute of Medical Science, The University of Tokyo, Minato-city, Tokyo, Japan.; Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Moroyama, Japan., Rosengarten O; Medical Gyneco-Oncology Unit, Shaare Zedek Medical Center, Jerusalem, Jerusalem, Israel., Nishio H; Department of Obstetrics and Gynecology, Keio Univesity School of Medicine, Tokyo, Japan.; Japanese Gynecologic Oncology Group (JGOG), Tokyo, Japan., Kim SI; Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea (the Republic of)., Mukopadhyay A; Kolkata Gynecological Oncology Trials and Translational Research Group (KolGOTrg), Kolkata, India., Piovano E; Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Torino, Piemonte, Italy., Cecere SC; Dep. of Experimental Uro-Gynecological Oncology, National Cancer Institute Institute for Hospitalization and Care Scientific Foundation Pascale, Naples, Italy., Kohn EC; Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA., Mukherjee U; GynaeOncology Trials Group UK (GCG UK), London, UK., Nasser S; Department of Gynecology with Center of Oncological Surgery, Charite Universitatsmedizin Berlin, Berlin, Germany.; Pan-Arabian Research Society of Gynecological Oncology, Berlin, Germany., Lindemann K; Department of gynecological oncology, Oslo University Hospital, Oslo, Norway.; Nordic Society of Gynaecological Oncology (NSGO), Copenhagen, Denmark., Croke J; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Chen X; Tongji University Dongfang Hospital, Shanghai, Shanghai, China., Geissler F; Department of Gynecology and Gynecological Oncology, Hospital for Women, University Hospital Basel, Basel, Switzerland.; Swiss GO Trial Group, Basel, Switzerland., Bookman MA; The Gynecologic Cancer InterGroup, Kingston, Ontario, Canada.; Kaiser Permanente Northern California, Oakland, California, USA.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Nov 04; Vol. 34 (11), pp. 1677-1684. Date of Electronic Publication: 2024 Nov 04.
Autor:
Lee JM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Brady MF; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY., Miller A; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY., Moore RG; Obstetrics and Gynecology, University of Rochester, Rochester, NY., MacKay H; Medical Oncology & Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., McNally L; Gynecologic Oncology, Duke University Medical Center, Duke Cancer Institute, Durham, NC., Lea J; University of Texas Southwestern Medical Center, Dallas, TX., Street D; Oklahoma Cancer Specialists and Research Institute, Tulsa, OK., Lheureux S; Princess Margaret Cancer Centre, Cancer Clinical Research Unit, Toronto, Ontario, Canada., McDonald ME; Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA., Duska LR; University of Virginia Cancer Center, Charlottesville, VA., Cantuaria G; University Gynecologic Oncology, Northside Hospital, Cumming, GA., Kavecansky J; Kaiser Permanente NCI Community Oncology Research Program, Antioch, CA., Leath CA 3rd; University of Alabama at Birmingham/Deep South Research Consortium, Birmingham, AL., Powell M; Washington University-Siteman Cancer, St Louis, MO., Cadungog MG; Christiana Care Gynecologic, Newark, DE., Rose PG; Cleveland Clinic Gynecologic Oncology, Cleveland, OH., Kim YM; University of Ulsan College of Medicine, ASAN Medical Center, Seoul, South Korea., Huang HQ; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY., Provencher M; CCTG Study Chair, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada., Wenzel LB; University of California, Irvine, Irvine, CA., Bookman MA; Kaiser Permanente Northern California, San Francisco, CA., Kohn EC; Gynecologic Cancer Therapeutics, National Cancer Institute, Rockville, MD., Secord AA; Gynecologic Oncology, Duke University Medical Center, Duke Cancer Institute, Durham, NC.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 03, pp. JCO2400683. Date of Electronic Publication: 2024 Oct 03.
Autor:
Brown J; Atrium Health Levine Cancer, Wake Forest University Comprehensive Cancer Center, Charlotte, NC, United States of America. Electronic address: Jubilee.Brown@Atriumhealth.org., Miller A; NRG Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address: Austin.Miller@RoswellPark.org., Holman LL; University of Oklahoma, Oklahoma City, OK, United States of America. Electronic address: Laura-L-Holman@ouhsc.edu., Backes F; The Ohio State University, Columbus, OH, United States of America. Electronic address: Floor.Backes@OSUMC.edu., Nagel C; Case Western Reserve University, Cleveland, OH, United States of America. Electronic address: Christa.Nagel@OSUMC.edu., Bender D; University of Iowa, Iowa City, IA, United States of America. Electronic address: David-Bender@UIowa.edu., Miller DS; University of Texas Southwestern Medical Center, Dallas, TX, United States of America. Electronic address: David.Miller@UTSouthwestern.edu., Powell MA; Washington University, St. Louis, MO, United States of America. Electronic address: mpowell@wustl.edu., Westin SN; The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America. Electronic address: swestin@mdanderson.org., Bonebrake A; Cancer Research for the Ozarks, Springfield, MO, United States of America. Electronic address: albert.bonebrake@coxhealth.com., Muller CY; University of New Mexico, Albuquerque, NM, United States of America. Electronic address: CMuller@salud.unm.edu., Secord AA; Duke University, Durham, NC, United States of America. Electronic address: secor002@MC.Duke.edu., Crane E; Atrium Health Levine Cancer, Wake Forest University Comprehensive Cancer Center, Charlotte, NC, United States of America. Electronic address: Erin.crane@atriumhealth.org., Schorge J; University of Tennessee Health Science Center -, Memphis, TN, United States of America. Electronic address: jschorge@uthsc.edu., Tew WP; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: TewW@mskcc.org., Sood AK; The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America. Electronic address: asood@mdanderson.org., Bookman MA; Department of Medical Oncology, Kaiser-Permanente Northern California, San Francisco, CA, United States of America. Electronic address: Michael.A.Bookman@kp.org., Aghajanian C; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: aghajanc@MSKCC.org., Gershenson DM; The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America. Electronic address: DGershen@mdanderson.org.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Sep 11; Vol. 190, pp. 283-290. Date of Electronic Publication: 2024 Sep 11.
Autor:
Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: c.l.creutzberg@lumc.nl., Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea., Eminowicz G; Department of Clinical Oncology, University College London Hospital, London, UK., Allanson E; Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, Perth, WA, Australia., Eberst L; Department of Medical Oncology, Institut de Cancérologie de Strasbourg, Strasbourg, France., Kim SI; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea., Nout RA; Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, Netherlands., Park JY; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea., Lorusso D; Gynecologic Oncology Unit, Humanitas San Pio X, Milan, Italy; Humanitas University Rozzano, Milan, Italy., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, VIC, Australia., Ottevanger PB; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Brand A; Department of Gynaecological Oncology, Westmead Hospital and University of Sydney, Sydney, NSW, Australia., Mezzanzanica D; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Oza A; Division of Medical Oncology and Hematology, UHN - Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Pothuri B; Perlmutter Cancer Center, NYU Langone Health, New York, NJ, USA; Diversity and Health Equity for Clinical Trials, GOG-Foundation, Philadelphia, PA USA., Batley T; Ko Ngai Tūhoe te iwi, Kaitauwhiro Mātātahi Mokopuna Ora, Te Pūtahitanga o Te Waipounamu, Christchurch, New Zealand., Gordon C; Canadian Cancer Trials Group, London, ON, Canada., Mitra T; Kolkata Gynecological Oncology Trials and Translational Research Group (KolGOTrg), New Town, Kolkata, India., White H; Peaches Womb Cancer Trust, Manchester, UK; Cancer Research Advocates Forum, London, UK., Howitt B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Matias-Guiu X; Department of Pathology, Hospital U de Bellvitge, University of Barcelona, Barcelona, Spain; Department of Pathology, Hospital U Arnau de Vilanova, University of Lleida, Lleida, Spain., Ray-Coquard I; Centre Leon Berard and Université Claude Bernard, Lyon, France., Gaffney D; Huntsman Cancer Institute, Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA., Small W Jr; Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, IL, USA., Miller A; Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Concin N; Department of Gynaecology and Gynaecological Oncology, Medical University of Vienna, Vienna, Austria; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria., Powell MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA., Stuart G; Department of Obstetrics and Gynecology, University of British Colombia, Vancouver, BC, Canada., Bookman MA; Kaiser Permanente Northern California, San Francisco, CA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. e420-e431.
Autor:
Landen CN; Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA., Buckanovich RJ; UPMC Hillman Cancer Center and Magee-Womens Research Institute and Foundation, Pittsburgh, PA., Sill MW; Clinical Trials Development Division, NRG Oncology Statistical and Data Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Mannel RS; University of Oklahoma Health Sciences, Stephenson Cancer Center, Oklahoma City, OK., Walker JL; University of Oklahoma Health Sciences, Stephenson Cancer Center, Oklahoma City, OK., DiSilvestro PA; Women & Infants Program in Women's Oncology, Providence, RI., Mathews CA; Women & Infants Program in Women's Oncology, Providence, RI., Mutch DG; Gynecologic Oncology, Washington University, St Louis, MO., Hernandez ML; Mercy Clinic Women's Oncology-Whiteside, Springfield, MO., Martin LP; Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA., Bishop E; Froedtert & Medical College of Wisconsin, Milwaukee, WI., Gill SE; Gynecologic Oncology, SJC Oncology Services-Georgia, LLC, Savannah, GA., Gordinier ME; Norton Children's Hospital, Louisville, KY., Burger RA; Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA.; Mersana Therapeutics, Cambridge, MA., Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Liu JF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Moore KN; University of Oklahoma Health Sciences, Stephenson Cancer Center, Oklahoma City, OK., Bookman MA; Department of Medical Oncology, Kaiser-Permanente Northern California, San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 20; Vol. 42 (21), pp. 2537-2545. Date of Electronic Publication: 2024 May 22.
Autor:
Sia TY; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: siat@mskcc.org., Tew WP; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: teww@mskcc.org., Purdy C; Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address: purdyc@nrgoncology.org., Chi DS; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: chid@mskcc.org., Menzin AW; North Shore-Long Island Jewish Medical Center, Manhasset, NY, United States of America. Electronic address: amenzin@northwell.edu., Lovecchio JL; North Shore-Long Island Jewish Medical Center, Manhasset, NY, United States of America. Electronic address: jlovecch@northwell.edu., Bookman MA; Gynecologic Oncology Therapeutics, Kaiser Permanente, San Francisco, CA, United States of America. Electronic address: Michael.A.Bookman@kp.org., Cohn DE; Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America. Electronic address: David.Cohn@osumc.edu., Teoh DG; University of Minnesota Medical Center, Minneapolis, MN, United States of America. Electronic address: dkteoh@umn.edu., Friedlander M; Department of Medical Oncology, Prince of Wales Hospital and Prince of Wales Clinical School, UNSW, Sydney, New South Wales, Australia. Electronic address: Michael.Friedlander@health.nsw.gov.au., Bender D; University of Iowa Hospitals, Iowa City, IA, United States of America. Electronic address: David-bender@uiowa.edu., Mutch DG; Washington University, St. Louis, MO, United States of America. Electronic address: mutchd@wustl.edu., Gershenson DM; MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: dgershen@mdanderson.org., Tewari KS; University of California, Irvine, Orange, CA, United States of America. Electronic address: ktewari@hs.uci.edu., Wenham RM; Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America. Electronic address: Robert.wenham@moffitt.org., Wahner Hendrickson AE; Mayo Clinic, Rochester, MN, United States of America. Electronic address: WahnerHendrickson.Andrea@mayo.edu., Lee RB; Tacoma General Hospital, Tacoma, WA, United States of America. Electronic address: rogerblee@aol.com., Gray HJ; Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Electronic address: hgray@uw.edu., Secord AA; Duke University Medical Center, Durham, NC, United States of America. Electronic address: angeles.secord@duke.edu., Van Le L; University of North Carolina, Chapel Hill, NC, United States of America. Electronic address: linda_van_le@med.unc.edu., Lichtman SM; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: LichtmaS@mskcc.org.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2023 Jun; Vol. 173, pp. 130-137. Date of Electronic Publication: 2023 May 04.
Autor:
You B; Faculté de Médecine Lyon-Sud, EA 3738 CICLY, Univ Lyon, Université Claude Bernard Lyon 1, GINECO, Lyon, France.; Centre d'Investigation des Thérapeutiques en Oncologie et Hématologie de Lyon (CITOHL), Hospices Civils de Lyon (IC-HCL), Lyon, France., Sehgal V; AbbVie, North Chicago, IL., Hosmane B; AbbVie, North Chicago, IL., Huang X; AbbVie, North Chicago, IL., Ansell PJ; AbbVie, North Chicago, IL., Dinh MH; AbbVie, North Chicago, IL., Bell-McGuinn K; AbbVie, North Chicago, IL., Luo X; AbbVie, North Chicago, IL., Fleming GF; University of Chicago Medicine, Chicago, IL., Friedlander M; Prince of Wales Clinical School UNSW and Prince of Wales Hospital and ANZGOG, Randwick, New South Wales, Australia., Bookman MA; Kaiser Permanente Northern California, San Francisco, CA., Moore KN; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK., Steffensen KD; Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark., Coleman RL; US Oncology Research, The Woodlands, TX., Swisher EM; University of Washington, Seattle, WA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 01; Vol. 41 (1), pp. 107-116. Date of Electronic Publication: 2022 Jul 22.
Autor:
You B; Université Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EMR UCBL/HCL 3738, Lyon, France GINECO, Paris, France.; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, GINECO-GINEGEPS, Lyon, France., Purdy C; Clinical Trial Development Division, Biostatistics and Bioinformatics Department, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Copeland LJ; The Ohio State University, James Cancer Hospital, Columbus, OH., Swisher EM; Division of Gynecologic Oncology, Department of Ob/Gyn, University of Washington, Seattle, WA., Bookman MA; Director, Gynecologic Oncology Therapeutics, Kaiser Permanente Northern California, San Francisco, CA., Fleming G; Hematology and Oncology, The University of Chicago Medicine, Chicago, IL., Coleman R; Chief Scientific Officer, US Oncology Research, The Woodlands, TX., Randall LM; Division of Gynecologic Oncology, Virginia Commonwealth University, School of Medicine, Richmond, VA., Tewari KS; UC Irvine Medical Center, Orange, CA., Monk BJ; HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ., Mannel RS; The University of Oklahoma, Oklahoma City, OK., Walker JL; The University of Oklahoma, Oklahoma City, OK., Cappuccini F; UC Irvine Medical Center, Orange, CA., Cohn D; The Ohio State University, James Cancer Hospital, Columbus, OH., Muzaffar M; Internal Medicine, East Carolina University, Greenville, NC., Mutch D; Washington University School of Medicine, Siteman Cancer Center, St Louis, MO., Wahner-Hendrickson A; Division of Medical Oncology, Mayo Clinic, Rochester, MN., Martin L; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA.; Mersana Therapeutics, Cambridge, MA., Colomban O; Université Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EMR UCBL/HCL 3738, Lyon, France GINECO, Paris, France.; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, GINECO-GINEGEPS, Lyon, France., Burger RA; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA.; Mersana Therapeutics, Cambridge, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Dec 01; Vol. 40 (34), pp. 3965-3974. Date of Electronic Publication: 2022 Oct 17.
Autor:
Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; University Hospitals Leuven, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Gonzalez-Martin A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Clinica Universidad de Navarra, Madrid, Spain; Program for Solid Tumors at Madrid, and Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain., Lorusso D; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy; Fondazione Policlinico Gemelli IRCCS, Rome, Italy., Gourley C; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Mirza MR; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark., Kurtz JE; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Strasbourg Cancer Institute, Strasbourg, France., Okamoto A; Japanese Gynecologic Oncology Group (JGOG), Tokyo, Japan; The Jikei University School of Medicine, Tokyo, Japan., Moore K; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; OU Health Stephenson Cancer Center, Oklahoma City, OH, USA., Kridelka F; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; Centre Hospitalier Universitaire de Liège, Liège, Belgium., McNeish I; National Cancer Research Institute (NCRI), London, UK; Department of Surgery and Cancer, Imperial College London, London, UK., Reuss A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Coordinating Center for Clinical Trials, Philipps University, Marburg, Germany., Votan B; Association de Recherche Cancers Gynécologiques (ARCAGY)-GINECO, Paris, France., du Bois A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Kliniken Essen Mitte (KEM), Essen, Germany., Mahner S; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; University Hospital, Ludwig Maximilians University, Munich, Germany., Ray-Coquard I; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Centre Leon Berard and University Claude Bernard Lyon I, Lyon, France., Kohn EC; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Berek JS; Women's Cancer Research Network-Cooperative Gynecologic Oncology Investigators (WCRN-COGI), Fresno, CA; Stanford Cancer Institute, Stanford, CA, USA., Tan DSP; Asia Pacific Gynecologic Oncology Trials Group (APGOT), Seoul, South Korea; Gynecologic Cancer Group Singapore (GCGS), Singapore; Cancer Science Institute, National University of Singapore, Singapore., Colombo N; Mario Negri Gynecologic Oncology (MaNGO), Milan, Italy; European Institute of Oncology, Milan, Italy; University of Milano-Bicocca, Milan, Italy., Zang R; Shanghai Gynecologic Oncology Group (SGOG), Shanghai, China; Zhongshan Hospital, Fudan University, Shanghai, China., Concin N; AGO -Austria, Innsbruck, Austria; Kliniken Essen Mitte (KEM), Essen, Germany; Medical University of Innsbruck, Innsbruck, Austria., O'Donnell D; Cancer Trials Ireland (CTI), Dublin, Ireland; St James's Hospital, Dublin, Ireland., Rauh-Hain A; Global Gynecologic Oncology Consortium (G-GOC), Houston, TX, USA; MD Anderson Cancer Center, The University of Texas, Houston, TX, USA., Herrington CS; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Marth C; AGO -Austria, Innsbruck, Austria; Medical University of Innsbruck, Innsbruck, Austria., Poveda A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Hospital Quironsalud, Valencia, Spain., Fujiwara K; Gynecologic Cancer Clinical Trials and Investigation Consortium (GOTIC), North Kanto, Japan; Saitama Medical University International Medical Center, Saitama, Japan., Stuart GCE; Canadian Cancer Trials Group (CCTG), Kingston, ON, Canada; University of British Columbia, Vancouver, BC, Canada., Oza AM; Princess Margaret Hospital Consortium (PMHC), Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bookman MA; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; San Francisco Medical Center, San Francisco, CA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Aug; Vol. 23 (8), pp. e374-e384.